Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Olivier J.F. Wouters, Ph.D.

Concepts (96)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug Industry1220247893.690 Why?
Drug Costs9202411842.100 Why?
Commerce520246041.990 Why?
Lobbying22024321.640 Why?
Technology Assessment, Biomedical220243051.540 Why?
Drugs, Generic420234481.380 Why?
Drug Approval420248161.280 Why?
Costs and Cost Analysis7202216791.220 Why?
Research5202319731.120 Why?
United States Food and Drug Administration7202416750.940 Why?
Drugs, Essential12024700.910 Why?
Health Policy6202326780.860 Why?
Nebulizers and Vaporizers120231370.800 Why?
Patents as Topic120231120.770 Why?
Albuterol120222120.770 Why?
Civil Defense120231150.770 Why?
Economic Competition120232180.730 Why?
Bronchodilator Agents120225060.650 Why?
Economics, Pharmaceutical12018880.610 Why?
Immunization Programs120212680.610 Why?
Politics220208150.550 Why?
Medical Savings Accounts12016340.530 Why?
Social Justice120204780.510 Why?
Drug and Narcotic Control220171450.490 Why?
Disclosure120207380.470 Why?
Tropical Medicine12014510.450 Why?
Neglected Diseases12014660.440 Why?
Decision Support Systems, Clinical1202211620.430 Why?
National Health Programs220204420.430 Why?
Patient Care Management120153030.400 Why?
Medical Oncology1202423210.400 Why?
Cost Savings120179200.400 Why?
Developing Countries1202428800.390 Why?
Health Expenditures3202423590.390 Why?
Health Services Accessibility3202453960.380 Why?
Health Care Reform2202312450.370 Why?
Medicare Part D220243540.330 Why?
United States162024723630.320 Why?
Quality-Adjusted Life Years1201517240.320 Why?
Negotiating320241480.320 Why?
Artificial Intelligence1202225570.300 Why?
Benchmarking2202410430.300 Why?
Public Sector220182650.250 Why?
Europe4202334330.230 Why?
Insurance, Health1201625000.220 Why?
Medicare Part B120231170.210 Why?
Pharmaceutical Preparations2202010930.200 Why?
South Africa2201818210.200 Why?
Humans3020247602610.190 Why?
Developed Countries120244430.190 Why?
Renal Insufficiency, Chronic1201522960.180 Why?
Delivery of Health Care3202453240.170 Why?
Technology120222920.170 Why?
European Union120201570.170 Why?
State Medicine120202130.160 Why?
Resource Allocation120213490.160 Why?
World Health Organization1202413190.150 Why?
Health Facilities120225780.140 Why?
Legislation, Pharmacy1201630.140 Why?
Income1202418760.130 Why?
Private Sector120183980.130 Why?
Cyprus12015960.130 Why?
Singapore120162870.120 Why?
International Cooperation1202114360.120 Why?
Pandemics3202386210.110 Why?
China2202023400.110 Why?
Meta-Analysis as Topic2201713750.110 Why?
Disease Outbreaks1202317590.110 Why?
Deductibles and Coinsurance120163160.110 Why?
Financing, Personal120163090.110 Why?
Cost Sharing120154100.100 Why?
Reimbursement Mechanisms120156640.080 Why?
Cardiovascular Diseases12015157400.080 Why?
Statistics as Topic1201523630.080 Why?
Biomedical Research1202434210.080 Why?
Patient Acceptance of Health Care1202131590.070 Why?
Drug Prescriptions1201516730.060 Why?
Evidence-Based Medicine1201736960.060 Why?
Time Factors22024401330.060 Why?
Anti-Bacterial Agents1202274000.060 Why?
Models, Theoretical1201535610.050 Why?
Feasibility Studies1201452010.050 Why?
Kidney Failure, Chronic1201524690.050 Why?
Hypoglycemic Agents1201531490.050 Why?
Health Care Costs1201632570.050 Why?
Cost-Benefit Analysis1201555070.050 Why?
Cross-Sectional Studies12022259280.050 Why?
Africa120217070.040 Why?
Comparative Effectiveness Research120247180.040 Why?
Disease Progression12015135050.040 Why?
Journal Impact Factor120151560.030 Why?
Diabetes Mellitus, Type 212015122810.020 Why?
Medicare1202467710.020 Why?
Randomized Controlled Trials as Topic12017103400.010 Why?
Reproducibility of Results12015200480.010 Why?
Aged120231689950.010 Why?
Wouters's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (96)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.